Magicell-NK

Autologous ex vivo expanded and activated natural killer cells · Medigen Biotechnology Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Magicell-NK, covering 2025-09-23 to 2025-09-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection Study [Phase 1]

See pricing